During the past decade, Hawaii Cancer Care Inc-Liliha conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 89 clinical trials were completed, i.e. on average, 91.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 48 clinical trials were completed. i.e. 208.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hawaii Cancer Care Inc-Liliha" #1 sponsor was "National Cancer Institute (NCI)" with 69 trials, followed by "SWOG Cancer Research Network" with 52 trials sponsored, "Alliance for Clinical Trials in Oncology" with 40 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hawaii Cancer Care Inc-Liliha" #1 collaborator was "National Cancer Institute (NCI)" with 118 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Hawaii Cancer Care Inc-Liliha" are "Breast Cancer" (20 trials), "Prostate Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Hawaii Cancer Care Inc-Liliha" in a lesser frequency.

Most popular intervention types in "Hawaii Cancer Care Inc-Liliha" are "Drug" (156 trials), "Other" (110 trials), "Biological" (66 trials), "Procedure" (41 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (21 trials), "Computed Tomography" (19 trials) and "Biospecimen Collection" (17 trials). Other intervention names were less common.

The vast majority of trials in "Hawaii Cancer Care Inc-Liliha" are 151 trials for "All" genders, 34 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Hawaii Cancer Care Inc-Liliha". undefined are not yet recruiting, 31 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Hawaii Cancer Care Inc-Liliha, 5 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hawaii Cancer Care Inc-Liliha, 7 "Phase 1" clinical trials were conducted, 103 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Hawaii Cancer Care Inc-Liliha has several departments that took part in Clinical trials: "Hawaii Cancer Care Inc - Waterfront Plaza" - 190 trials